Tumor marker |
Alpha-fetoprotein (AFP) | Carcinoembryonic antigen (CEA) | Glycochain antigen CA-125 |
Glycochain antigen CA-153 | Glycochain antigen CA-199 | Glycochain antigen CA-242 |
Glycochain antigen CA-724 | Glycochain antigen CA-50 | Neuron-specific enolase (NSE) |
Cytokeratin 19 fragment (CYFRA21-1) | Total prostate-specific antigen (TPSA) | Free prostate-specific antigen (FPSA) |
Free to total PSA ratio (FPSATPSA) | α-L-fucosidase (AFU) | β2-microglobulin (β2-MG) |
Malignant tumor-specific growth Factor (TSGF) | Vascular endothelial growth factor (VEGF) | Squamous cell carcinoma-associated antigen (SCC) |
Tumor necrosis factor α (TNF-α) | Interleukin Ⅵ (IL-6) | Gastrin-releasing peptide Precursor (Pro-grp) |
Prostate Health Index (PHI) 【TPSA, FPSA, p2PSA】 | Gastrin 17 (G-17) | Pepsinogen Ⅰ (PGI) |
Pepsinogen Ⅱ (PG-ⅱ) | Human epididymal protein 4 (HE4) | 5 male tumor markers [AFP, CEA, CA199, T-PSA, CA125] |
5 female tumor markers [AFP, CEA, CA199, CA153, CA125] | 4 liver tumor markers [AFP, CEA, CA199, Fer] | 5 ovarian tumor markers [AFP, CEA, CA199, CA125, β-HCG] |
4 ovarian tumor markers [AFP, CEA, CA125, CA724] | 2 prostate tumor markers [T-PSA, F-PSA] | 4 gastric cancer markers [CA724, CEA, CA199, CA242] |
5 lung cancer markers [CEA, NSE, CY211, CA125, SCC] | 4 markers of colon and rectal cancer [CEA, CA199, CA50, CA242] | 4 biomarkers for pancreatic cancer [CEA, CA199, CA50, CA125] |
There were 4 breast cancer markers [CEA, CA153, Fer, β-HCG] | 3 breast cancer markers [CEA, CA153, β-HCG] | Detection of human SDC2 gene methylation |
